Novavax’s Vaccine Candidate Shows Nearly 90% Efficacy in UK
Novavax, a vaccine development company headquartered in Gaithersburg, says its COVID-19 vaccine candidate showed 89.3% efficacy in UK clinical trials. The UK study enrolled more than 15,000 volunteers, according to… Read More